Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection
Δ9-tetrahydrocannabinol (THC), the chief psychoactive ingredient of cannabis, acts in the brain primarily via cannabinoid CB1 receptors. These receptors are implicated in several forms of synaptic plasticity – depolarization-induced suppression of excitation (DSE), metabotropic suppression of excita...
Saved in:
| Main Authors: | Michaela Dvorakova, Ken Mackie, Alex Straiker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000313 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IUPHAR Review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia
by: Brian Dean
Published: (2024-12-01) -
Long-term muscarinic inhibition increases intrinsic excitability through the upregulation of A-type potassium currents in cortical neurons
by: Denise Riquelme, et al.
Published: (2025-05-01) -
Is muscarinic receptor agonist effective and tolerant for schizophrenia?
by: Xiaonan Guo, et al.
Published: (2025-04-01) -
GABAergic synaptic components are largely preserved across human and mouse neuronal models
by: Beatriz Rebollo, et al.
Published: (2025-05-01) -
Reduced M3 muscarinic acetylcholine receptor expression in gestational diabetes mellitus: implications for placental dysfunction and vascular regulation
by: Süleyman Cemil Oğlak, et al.
Published: (2025-12-01)